Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
03/2011
03/16/2011EP2295454A1 SLO2, a novel potassium channel protein from human brain
03/16/2011EP2295447A1 GIPs, a family of polypeptides with transcription factor activity that interact with Goodpasture antigen binding protein
03/16/2011EP2295080A2 B-cell reduction using CD37-specific and CD20-specific binding molecules
03/16/2011EP2295074A1 Anti-neovasculature preparations for treating cancer
03/16/2011EP2295069A1 Treatment of neurological disorders with haematopoietic growth factors
03/16/2011EP2295065A1 Modified heat shock protein-antigenic peptide complex
03/16/2011EP2295060A2 Stabilization of hypoxia inducible factor (HIF) alpha
03/16/2011EP2295059A2 Stabilization of hypoxia inducible factor (HIF) alpha
03/16/2011EP2294917A1 Transgenic animals expressing antibodies specific for genes of interest and uses thereof
03/16/2011EP2294915A2 Nucleic acid constructs and methods for producing altered seed oil compositions
03/16/2011EP2294201A1 Diacylglycerol acyltransferases from flax
03/16/2011EP2294187A2 Differentiation of multi-lineage progenitor cells to pancreatic cells
03/16/2011EP2294186A2 Inducing cell death by inhibiting adaptive heat shock response
03/16/2011EP2294185A2 Multipotent adult stem cell population
03/16/2011EP2294184A1 Treatment of eye diseases and excessive neovascularization using a combined therapy
03/16/2011EP2294183A2 Mesenchymal stem cells, compositions, and methods for treatment of cardiac tissue damage
03/16/2011EP2294182A1 Multipotent stem cell cultures
03/16/2011EP2294181A2 Modulation of smrt expression
03/16/2011EP2294089A2 Anti-fn14 antibodies and uses thereof
03/16/2011EP2173890B1 Biological active proteins having increased in vivo and/or vitro stability
03/16/2011EP2097453B1 Monoclonal antibodies against the human anti-müllerian hormone type ii receptor (amhr-ii)
03/16/2011EP1812046B1 Melanocortin receptor binding mimetibodies, compositions, methods and uses
03/16/2011EP1694828B1 Serum-free vero cell banking process
03/16/2011EP1572895B1 Methods for producing hyaluronan in a recombinant host cell
03/16/2011EP1564285B1 Method of obtaining a recombinant mammalian myeloma cell lines adapted to growth in serum- and protein-free media
03/16/2011EP1551876B1 Antibodies that bind cell-associated ca 125/0722p and methods of use thereof
03/16/2011EP1404848B1 Gene expression in plastids based on replicating vectors
03/16/2011EP1351565B1 Chemical inhibitors of mismatch repair
03/16/2011EP1135532B1 Fluorescent proteins from non-bioluminescent species of class anthozoa, genes encoding such proteins and uses thereof
03/16/2011CN201762336U Reagent case convenient for in vitro construction of mammary gland acinar models
03/16/2011CN201762308U Kit convenient for mammary epithelial cell isolation and identification
03/16/2011CN1953767B Regulatory T cells suppress autoimmunity
03/16/2011CN1951177B A seedling environment training method for ginger tissue cultured test-tube seedling
03/16/2011CN101985634A GFP membrane type expression vector and method for sorting vector-transfected positive cells
03/16/2011CN101985622A Promoter BgIosP572 and preparation method and application thereof
03/16/2011CN101985621A Molecular mark SIsvo188 closely linked with herbicide-resistant gene in foxtail millet
03/16/2011CN101985620A Molecular marker SIsv1223 closely linked with millet herbicide-resistant gene
03/16/2011CN101985612A Method for preparing mesenchymal stem cells in large scale by utilizing bioreactor
03/16/2011CN101985611A Mammalian cell culture media which comprise supernatant from Cohn fractionation stages and use thereof
03/16/2011CN101985476A Preparation, identification and application of antihuman NKp30 monoclonal antibody
03/16/2011CN101985474A Monoclonal antibody TBCA6 resistant to mycobacterium tuberculosis CFP-10 and application
03/16/2011CN101985473A Monoclonal antibody TBEF3 of tubercle bacillus-resistant ESAT-6 and application thereof
03/16/2011CN101985472A Monoclonal antibody TBCD6 resistant to mycobacterium tuberculosis CFP-10 and application
03/16/2011CN101985465A Soybean GmPHR1 gene and encoded protein and application thereof
03/16/2011CN101985052A Skin substitute for automatically capturing endothelial progenitor cells and promoting vascularization and construction method thereof
03/16/2011CN101407815B Use of glycine-N-methyltransferase (GNMT) in preparing medicine for preventing and treating disease derived from flavacin
03/15/2011US7906711 Soybean cultivar 6214260
03/15/2011US7906708 Slow-maturing, determinate peas
03/15/2011US7906707 Nucleic acid molecules encoding enzymes having fructosyltransferase activity, and their use
03/15/2011US7906638 Chimeric nucleic acids encoding polypeptides comprising CD70 and Fas ligand domains
03/15/2011US7906637 Compositions and methods for inducing or inhibiting activities of selected human cells
03/15/2011US7906629 Protease inhibitor conjugates and antibodies useful in immunoassay
03/15/2011US7906627 Chimeric human sweet-umami and umami-sweet taste receptors
03/15/2011US7906490 Using vector transformation to generate transgenic cells expressing interfering RNA sequences; treatment and prevention of metabolic disorders
03/15/2011US7906487 Method of utilizing physiological activity of rare saccharide and composition containing rare saccharide
03/15/2011US7906484 Complex for transferring an anionic substance into a cell
03/15/2011US7906335 Nutrient broth for propagation of nematophagus fungi
03/15/2011US7906334 Method for reproducing conifers by somatic embryogenesis using lactose as a carbon source
03/15/2011US7906333 Surface modification of polysaccharide, the modified polysaccharide, and method of culturing and recovery cells using the same
03/15/2011US7906332 Method of preparing basement membrane, method of constructing basement membrane specimen, reconstituted artificial tissue using the basement membrane specimen and process for producing the same
03/15/2011US7906331 Methods for identifying stem cells expressing breast cancer resistance protein (BCRP)
03/15/2011US7906330 Two cell population comprising chondrocyte precursors and human embryonic stem cells
03/15/2011US7906329 Transgenic cells expressing anti-human squamous-cell carcinoma monoclonal antibody with enhanced antibody dependent cellular cytotoxicity (ADCC); drug targeting and delivery
03/15/2011US7906328 Cell lines that express hetero oligomeric taste receptors
03/15/2011US7906327 Dual expression vector system for antibody expression in bacterial and mammalian cells
03/15/2011US7906323 Feedback controlled bioreactor for propagation of preferential cells
03/15/2011US7906311 For production of viruses causing porcine reproductive and respiratory syndrome (PRRS)
03/15/2011US7906300 Sodium/potassium ATPase regulation
03/15/2011US7906298 Thermostable Photinus pyralis luciferase mutant
03/15/2011US7906282 Synthetic nucleic acid molecule compositions and methods of preparation
03/15/2011US7906277 Compound and methods for diagnosis of tuberculosis
03/15/2011US7906135 Medical device comprising polyhydroxyalkanoate having pyrogen removed
03/15/2011US7906113 DNA viral vector comprising nucleotide seuences coding modified capsid protein for use in enhancement of heterologous gene transfer; improved exogenous gene expression
03/15/2011US7906111 Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor
03/15/2011US7906110 Rapid preparation of stem cell matrices for use in tissue and organ treatment and repair
03/15/2011CA2494698C Anti-idiotypic antibodies against factor viii inhibitor and uses thereof
03/15/2011CA2452005C Inhibition of apoptosis process and improvement of cell performance
03/15/2011CA2429134C A method for generating genetically altered antigens
03/15/2011CA2422230C Bio-reactor device
03/15/2011CA2410297C Assembly of wild-type and chimeric influenza virus-like particles (vlps)
03/15/2011CA2392845C Maize mip synthase promoter
03/15/2011CA2338982C Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
03/15/2011CA2277192C Nuclear transfer with differentiated fetal and adult donor cells
03/15/2011CA2188422C Bifunctional protein, preparation and use
03/15/2011CA2163517C Surrogate tolerogenesis for the development of tolerance to xenografts
03/15/2011CA2094511C Analogs of botanic seed
03/10/2011WO2011029092A1 Klf family members regulate intrinsic axon regeneration ability
03/10/2011WO2011029053A1 Human embryonic stem cells for high throughout drug screening
03/10/2011WO2011029007A2 Human lymphoid tissue inducer (lti) cell compositions and methods of use
03/10/2011WO2011028880A2 Methods for enhancing genome stability and telomere elongation in embryonic stem cells
03/10/2011WO2011028811A2 Dual variable domain immunoglobulins and uses thereof
03/10/2011WO2011028795A2 Methods for extraction and purification of gangliosides
03/10/2011WO2011028690A1 Microbubble devices, methods and systems
03/10/2011WO2011028681A2 Biologic soft tissue arthroplasty spacer and joint resurfacing of wrist and hand
03/10/2011WO2011028673A2 A composition for delaying cellular senescence
03/10/2011WO2011028611A1 P2x7: inhibition of epithelial cancers and papillomas
03/10/2011WO2011028579A2 Aligning cells on wrinkled surface
03/10/2011WO2011028531A1 Generation of ctl lines with specificity against multiple tumor antigens or multiple viruses
03/10/2011WO2011028524A1 Substantially pure human retinal progenitor, forebrain progenitor, and retinal pigment epithelium cell cultures and methods of making the same
03/10/2011WO2011028390A1 Compositions and methods for potentiating interleukin-35